Cargando…

Medication Effectiveness with the Use of Tumor Necrosis Factor Inhibitors Among Texas Medicaid Patients Diagnosed with Rheumatoid Arthritis

BACKGROUND: Adalimumab (Humira [ADA]), etanercept (Enbrel [ETN]), and infliximab (Remicade [IFX]) are tumor necrosis factor (TNF) inhibitors indicated for the treatment of a variety of disorders. While their effectiveness has not been directly compared in a clinical trial, results from the majority...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oladapo, Abiola, Barner, Jamie C., Lawson, Kenneth A., Novak, Suzanne, Rascati, Karen L., Richards, Kristin M., Harrison, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437715/ https://www.ncbi.nlm.nih.gov/pubmed/24967519 http://dx.doi.org/10.18553/jmcp.2014.20.7.657

Ejemplares similares

Asthma Controller Medication Adherence, Risk of Exacerbation, and Use of Rescue Agents Among Texas Medicaid Patients with Persistent Asthma
por: Makhinova, Tatiana, et al.
Publicado: (2015)

Assessment of basal insulin adherence using 2 methodologies among Texas Medicaid enrollees with type 2 diabetes
por: Zhang, Hanxi, et al.
Publicado: (2020)

The association between hydroxyurea adherence and opioid utilization among Texas Medicaid enrollees with sickle cell disease
por: Kang, Hyeun Ah, et al.
Publicado: (2020)

Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis
por: Park, Haesuk, et al.
Publicado: (2015)

Adherence and Persistence to Prescribed Medication Therapy Among Medicare Part D Beneficiaries on Dialysis: Comparisons of Benefit Type and Benefit Phase
por: Park, Haesuk, et al.
Publicado: (2014)

Trends in off-label use of antipsychotic medications among Texas Medicaid children and adolescents from 2013 to 2016
por: Chen, Shuang, et al.
Publicado: (2021)

Identifying Patient Characteristics Associated with High Schizophrenia-Related Direct Medical Costs in Community-Dwelling Patients
por: Desai, Pooja R., et al.
Publicado: (2013)

Cost of tumor necrosis factor blockers per patient with rheumatoid arthritis in a multistate Medicaid population
por: Bonafede, Machaon, et al.
Publicado: (2014)

Improving Asthma Management: Patient–Pharmacist Partnership Program in Enhancing Therapy Adherence
por: Makhinova, Tatiana, et al.
Publicado: (2022)

Real-world opioid use among patients with migraine enrolled in US commercial insurance and risk factors associated with migraine progression
por: Shao, Qiujun, et al.
Publicado: (2022)

Predict Health Care Accessibility for Texas Medicaid Gap
por: Zhang, Jinting, et al.
Publicado: (2021)

Achieving Triple Aim Outcomes: An Evaluation of the Texas Medicaid Waiver
por: Revere, Lee, et al.
Publicado: (2020)

An Investigation of Health Management Perceptions and Wellness Behaviors in African American Males in Central Texas
por: Amuneke-Nze, Chibuokem G., et al.
Publicado: (2018)

The Impact of Medicaid Reform on Children’s Dental Care Utilization in Connecticut, Maryland, and Texas
por: Nasseh, Kamyar, et al.
Publicado: (2015)

Influence of tumor necrosis factor α in rheumatoid arthritis
por: Kulp, Werner, et al.
Publicado: (2005)

Demographic risk factors associated with elevated lead levels in Texas children covered by Medicaid.
por: Kurtin, D, et al.
Publicado: (1997)

Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor
por: Ernestam, Sofia, et al.
Publicado: (2006)

Extending Postpartum Medicaid Beyond 60 Days Improves Care Access and Uncovers Unmet Needs in a Texas Medicaid Health Maintenance Organization
por: Wang, Xiao, et al.
Publicado: (2022)

Use of the painDETECT tool in rheumatoid arthritis suggests neuropathic and sensitization components in pain reporting
por: Ahmed, Saqa, et al.
Publicado: (2014)

Body awareness in persons diagnosed with rheumatoid arthritis
por: Lööf, Helena, et al.
Publicado: (2014)

Response to Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis for Function and Pain is Affected by Rheumatoid Factor
por: Aberumand, Babak, et al.
Publicado: (2014)

Rheumatoid Arthritis: Refractory to Infliximab, a Tumor Necrosis Factor Inhibitor
por: Solehan, Hana Maizuliana bt, et al.
Publicado: (2011)

Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
por: Leandro, Maria J
Publicado: (2009)

Role of ultrasonography in diagnosing early rheumatoid arthritis and remission of rheumatoid arthritis - a systematic review of the literature
por: Ten Cate, David F, et al.
Publicado: (2013)

Variation in outpatient emergency department utilization in Texas Medicaid: a state-level framework for finding “superutilizers”
por: Delcher, Chris, et al.
Publicado: (2017)

Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
por: Shin, Sungsik, et al.
Publicado: (2016)

Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritis
por: Martínez-Santana, Virginia, et al.
Publicado: (2013)

Life-Threatening Gastrointestinal Mucosal Necrosis during Methotrexate Treatment for Rheumatoid Arthritis
por: Tsukada, Tomoya, et al.
Publicado: (2013)

Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis
por: Perpétuo, Inês P., et al.
Publicado: (2017)

Tumor necrosis factor α-induced adipose-related protein expression in experimental arthritis and in rheumatoid arthritis
por: Inoue, Asuka, et al.
Publicado: (2009)

An assessment of Parkinson’s disease medication treatment patterns in the Medicaid population
por: Johnsrud, Michael, et al.
Publicado: (2021)

How Would Medicaid Expansion Affect Texas Hospitals? Evidence From a Retrospective Quasi-Experimental Study
por: Saygili, Meryem
Publicado: (2022)

Expanding Medicaid to Reduce Human Immunodeficiency Virus Transmission in Houston, Texas: Insights From a Modeling Study
por: Lee, Francis, et al.
Publicado: (2023)

Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: Findings from TCR-Medicaid linked data
por: Farias, Albert J., et al.
Publicado: (2018)

Validation of rheumatoid arthritis diagnoses in health care utilization data
por: Kim, Seo Young, et al.
Publicado: (2011)

Prevalence of Thyroid Dysfunction in Newly Diagnosed Rheumatoid Arthritis Patients
por: Nazary, Kefayatullah, et al.
Publicado: (2021)

Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis
por: Yang, Nicole, et al.
Publicado: (2019)

Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis
por: Cannon, Grant W., et al.
Publicado: (2016)

Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors
por: Tanaka, Toshio, et al.
Publicado: (2014)

Tumor Necrosis Factor Inhibition and Head and Neck Cancer Recurrence and Death in Rheumatoid Arthritis
por: Phillips, Christopher, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2v00c5htfu0k9ahm7bckjolipt